Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Nephropathy”

278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 278 results

Not applicableActive Not RecruitingNCT04960514
What this trial is testing

Prospective Decision Impact Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2+1 more
Renalytix AI, Inc. 2,000
Large-scale testing (Phase 3)WithdrawnNCT02806362
What this trial is testing

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)

Who this might be right for
Chronic Hepatitis C Virus
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Looking for participantsNCT07374042
What this trial is testing

Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

Who this might be right for
Kidney Disease, Chronic
University Hospital, Clermont-Ferrand 100
Testing effectiveness (Phase 2)UnknownNCT03341845
What this trial is testing

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 40
Post-approval studies (Phase 4)Study completedNCT03451019
What this trial is testing

Different Effects of Non-calcium Phosphate Binders on Serum Calcium

Who this might be right for
Chronic Kidney Disease
Medical University of Lodz 34
Testing effectiveness (Phase 2)Study completedNCT03617536
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 269
Early research (Phase 1)Study completedNCT00626249
What this trial is testing

Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

Who this might be right for
Mild NephropathyModerate NephropathyDiabetes Mellitus
Mannkind Corporation 36
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT01136564
What this trial is testing

Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Erling Bjerregaard Pedersen 30
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Early research (Phase 1)Study completedNCT02199379
What this trial is testing

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

Who this might be right for
Renal ImpairmentDisease Severity
Eisai Inc. 26
Large-scale testing (Phase 3)Study completedNCT05075408
What this trial is testing

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

Who this might be right for
Chronic Kidney Disease Associated Moderate to Severe Pruritus
Galderma R&D 258
Testing effectiveness (Phase 2)WithdrawnNCT02848508
What this trial is testing

Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study

Who this might be right for
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens
Testing effectiveness (Phase 2)UnknownNCT00003604
What this trial is testing

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery

Who this might be right for
Kidney Cancer
Cancer Biotherapy Research Group 20
Post-approval studies (Phase 4)Study completedNCT03123406
What this trial is testing

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Kyowa Kirin China Pharmaceutical Co., Ltd. 750
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Early research (Phase 1)Study completedNCT01766154
What this trial is testing

Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal Insufficiency
Medicure 25
Next Page